RenovoRx
Price & Volume
Stats
See more52W Range | $0.70-$1.45 |
Market Cap | $38.9M |
Shares Short | 470,946 |
Financials
See moreRevenue (12 Mos) | $1.1M |
Revenue Growth (YoY) | 453.5% |
Gross Profit (12 Mos) | $796,000 |
Diluted EPS | -$0.32 |
News
See moreYahoo Finance • 28 days ago
Clinical Data Supporting Targeted Chemotherapeutic Delivery via RenovoRx’s TAMP™ Therapy Platform Presented at 2026 SIR Annual Scientific Meeting
Yahoo Finance • last month
RenovoRx Named to Fast Company’s Annual List of the World’s Most Innovative Companies of 2026
Yahoo Finance • last month
After-Hours Earnings Report for March 30, 2026 : PRGS, PHR, DMAC, AIRJ, SPCE, HQI, SGMO, RNXT, INLX, FTHM
Yahoo Finance • 2 months ago
RenovoRx announces $10 million private placement
About
CEO | Mr. Shaun R. Bagai |
CFO | Mr. Mark Voll |
Address | 2570 West El Camino Real, Mountain View, CA, United States, 94040 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 17 |